The mechanisms of controlling programmed death ligand-1 (PD-L1) at the transcription and protein acetylation levels in promoting breast cancer growth are presented. Overexpressed PD-L1 accelerated breast cancer growth in vitro and in vivo.
[Acta Pharmacologica Sinica]
Xu, F., Sun, H., Fang, R., Zhang, L., Shi, H., Wang, X., Fu, X., Li, X., Shi, X., Wu, Y., Ye, K., Zhang, W., & Ye, L. (2021). The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth. Acta Pharmacologica Sinica, 1–17. https://doi.org/10.1038/s41401-021-00631-6 Cite
0